These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24993912)

  • 21. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD; Kapsner RK; Osberg I
    Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge.
    Cataldo DD; Bettiol J; Noël A; Bartsch P; Foidart JM; Louis R
    Chest; 2002 Nov; 122(5):1553-9. PubMed ID: 12426252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD.
    Vignola AM; Paganin F; Capieu L; Scichilone N; Bellia M; Maakel L; Bellia V; Godard P; Bousquet J; Chanez P
    Eur Respir J; 2004 Dec; 24(6):910-7. PubMed ID: 15572531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation.
    Hoshino M; Nakamura Y; Sim J; Shimojo J; Isogai S
    J Allergy Clin Immunol; 1998 Nov; 102(5):783-8. PubMed ID: 9819295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction.
    Diaz AA; Hardin ME; Come CE; San José Estépar R; Ross JC; Kurugol S; Okajima Y; Han MK; Kim V; Ramsdell J; Silverman EK; Crapo JD; Lynch DA; Make B; Barr RG; Hersh CP; Washko GR;
    Ann Am Thorac Soc; 2014 Nov; 11(9):1371-8. PubMed ID: 25296268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
    Beeh KM; Beier J; Kornmann O; Buhl R
    Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of noninvasive methods in assessing airway inflammation and structural changes in asthma and COPD.
    Dar KA; Shahid M; Mubeen A; Bhargava R; Ahmad Z; Ahmad I; Islam N
    Monaldi Arch Chest Dis; 2012 Mar; 77(1):8-18. PubMed ID: 22662640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
    Vignola AM; Riccobono L; Profita M; Foresi A; Di Giorgi R; Guerrera D; Gjomarkaj M; Di Blasi P; Paggiaro PL
    Allergy; 2005 Dec; 60(12):1511-7. PubMed ID: 16266383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metalloproteinase-9 in induced sputum correlates with the severity of the late allergen-induced asthmatic response.
    Boulay ME; Prince P; Deschesnes F; Chakir J; Boulet LP
    Respiration; 2004; 71(3):216-24. PubMed ID: 15133340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity.
    Little SA; Sproule MW; Cowan MD; Macleod KJ; Robertson M; Love JG; Chalmers GW; McSharry CP; Thomson NC
    Thorax; 2002 Mar; 57(3):247-53. PubMed ID: 11867830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.
    Doherty GM; Kamath SV; de Courcey F; Christie SN; Chisakuta A; Lyons JD; Heaney LG; Ennis M; Shields MD
    Clin Exp Allergy; 2005 Sep; 35(9):1168-74. PubMed ID: 16164443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity.
    Chaudhuri R; McSharry C; Brady J; Donnelly I; Grierson C; McGuinness S; Jolly L; Weir CJ; Messow CM; Spears M; Miele G; Nocka K; Crowther D; Thompson J; Brannigan M; Lafferty J; Sproule M; Macnee W; Connell M; Murchison JT; Shepherd MC; Feuerstein G; Miller DK; Thomson NC
    J Allergy Clin Immunol; 2012 Mar; 129(3):655-663.e8. PubMed ID: 22305682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease.
    Cataldo D; Munaut C; Noël A; Frankenne F; Bartsch P; Foidart JM; Louis R
    Int Arch Allergy Immunol; 2000 Nov; 123(3):259-67. PubMed ID: 11112863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.
    Gupta S; Siddiqui S; Haldar P; Entwisle JJ; Mawby D; Wardlaw AJ; Bradding P; Pavord ID; Green RH; Brightling CE
    Thorax; 2010 Sep; 65(9):775-81. PubMed ID: 20805170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma.
    Barbaro MP; Spanevello A; Palladino GP; Salerno FG; Lacedonia D; Carpagnano GE
    Eur J Intern Med; 2014 Jan; 25(1):92-6. PubMed ID: 24070522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased matrix metalloproteinase-9 with elastolysis in nocturnal asthma.
    Pham DN; Chu HW; Martin RJ; Kraft M
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):72-8. PubMed ID: 12546341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma.
    Goleva E; Hauk PJ; Boguniewicz J; Martin RJ; Leung DY
    J Allergy Clin Immunol; 2007 Nov; 120(5):1065-72. PubMed ID: 17900681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
    Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environmental arsenic exposure and sputum metalloproteinase concentrations.
    Josyula AB; Poplin GS; Kurzius-Spencer M; McClellen HE; Kopplin MJ; Stürup S; Clark Lantz R; Burgess JL
    Environ Res; 2006 Nov; 102(3):283-90. PubMed ID: 16487958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.